CASP1 and infarction: They found that the NLRP3 inflammasome inhibitor MCC950 significantly reduced cerebral infarct volume, inhibited caspase-1 activation, attenuated inflammation, and stabilized the blood-brain barrier, thereby preventing I/R injury.